These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 33535181)
1. Identification of microRNA-16-5p and microRNA-21-5p in feces as potential noninvasive biomarkers for inflammatory bowel disease. Zhou R; Qiu P; Wang H; Yang H; Yang X; Ye M; Wang F; Zhao Q Aging (Albany NY); 2021 Feb; 13(3):4634-4646. PubMed ID: 33535181 [TBL] [Abstract][Full Text] [Related]
2. Circulating and Fecal microRNAs as Biomarkers for Inflammatory Bowel Diseases. Schönauen K; Le N; von Arnim U; Schulz C; Malfertheiner P; Link A Inflamm Bowel Dis; 2018 Jun; 24(7):1547-1557. PubMed ID: 29668922 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis. Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994 [TBL] [Abstract][Full Text] [Related]
4. Differential expression of serum miR-486 and miR-25 in ulcerative colitis and Crohn's disease: Correlations with disease activity, extent, and location. Abdelazim SA; Shaker OG; Ali O; El-Tawil M; Senousy MA Pathol Res Pract; 2023 Dec; 252():154910. PubMed ID: 37939427 [TBL] [Abstract][Full Text] [Related]
5. Tissue and serum miR-149-3p/5p in hospitalized patients with inflammatory bowel disease: Correlation with disease severity and inflammatory markers. Luo S; Chen XH Kaohsiung J Med Sci; 2024 Feb; 40(2):131-138. PubMed ID: 37997516 [TBL] [Abstract][Full Text] [Related]
6. Fecal neutrophil gelatinase-associated lipocalin as a biomarker for inflammatory bowel disease. Thorsvik S; Damås JK; Granlund AV; Flo TH; Bergh K; Østvik AE; Sandvik AK J Gastroenterol Hepatol; 2017 Jan; 32(1):128-135. PubMed ID: 27640344 [TBL] [Abstract][Full Text] [Related]
7. Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease. Fasseu M; Tréton X; Guichard C; Pedruzzi E; Cazals-Hatem D; Richard C; Aparicio T; Daniel F; Soulé JC; Moreau R; Bouhnik Y; Laburthe M; Groyer A; Ogier-Denis E PLoS One; 2010 Oct; 5(10):. PubMed ID: 20957151 [TBL] [Abstract][Full Text] [Related]
8. Whole Blood Profiling of T-cell-Derived microRNA Allows the Development of Prognostic models in Inflammatory Bowel Disease. Kalla R; Adams AT; Ventham NT; Kennedy NA; White R; Clarke C; Ivens A; Bergemalm D; Vatn S; Lopez-Jimena B; ; Ricanek P; Vatn MH; Söderholm JD; Gomollón F; Nowak JK; Jahnsen J; Halfvarson J; McTaggart S; Ho GT; Buck A; Satsangi J J Crohns Colitis; 2020 Dec; 14(12):1724-1733. PubMed ID: 32598439 [TBL] [Abstract][Full Text] [Related]
9. Serum long noncoding RNA H19/micro RNA-675-5p axis as a probable diagnostic biomarker in inflammatory bowel disease. Shaker OG; Safa A; Khairy A; Abozeid NF Mol Biol Rep; 2023 Nov; 50(11):9029-9036. PubMed ID: 37716920 [TBL] [Abstract][Full Text] [Related]
10. microRNA-mRNA Networks Linked to Inflammation and Immune System Regulation in Inflammatory Bowel Disease. Síbia CF; Quaglio AEV; Oliveira ECS; Pereira JN; Ariede JR; Lapa RML; Severino FE; Reis PP; Sassaki LY; Saad-Hossne R Biomedicines; 2024 Feb; 12(2):. PubMed ID: 38398024 [TBL] [Abstract][Full Text] [Related]
11. Altered mucosal expression of microRNAs in pediatric patients with inflammatory bowel disease. Béres NJ; Kiss Z; Sztupinszki Z; Lendvai G; Arató A; Sziksz E; Vannay Á; Szabó AJ; Müller KE; Cseh Á; Boros K; Veres G Dig Liver Dis; 2017 Apr; 49(4):378-387. PubMed ID: 28077249 [TBL] [Abstract][Full Text] [Related]
12. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling. Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916 [TBL] [Abstract][Full Text] [Related]
13. Circulating microRNA146b-5p is superior to C-reactive protein as a novel biomarker for monitoring inflammatory bowel disease. Chen P; Li Y; Li L; Yu Q; Chao K; Zhou G; Qiu Y; Feng R; Huang S; He Y; Chen B; Chen M; Zeng Z; Zhang S Aliment Pharmacol Ther; 2019 Mar; 49(6):733-743. PubMed ID: 30734320 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA Biomarkers in IBD-Differential Diagnosis and Prediction of Colitis-Associated Cancer. James JP; Riis LB; Malham M; Høgdall E; Langholz E; Nielsen BS Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114313 [TBL] [Abstract][Full Text] [Related]
16. Differential Gene Expression Profiles Involved in the Inflammations Due to COVID-19 and Inflammatory Bowel Diseases and the Investigation of Predictive Biomarkers. Aishwarya S; Gunasekaran K Biochem Genet; 2024 Feb; 62(1):311-332. PubMed ID: 37335372 [TBL] [Abstract][Full Text] [Related]
17. Elevated miRNA Inversely Correlates with Guz M; Dworzański T; Jeleniewicz W; Cybulski M; Kozicka J; Stepulak A; Celiński K Biomed Res Int; 2020; 2020():4250329. PubMed ID: 32775420 [TBL] [Abstract][Full Text] [Related]
18. Fecal MicroRNAs Show Promise as Noninvasive Crohn's Disease Biomarkers. Wohnhaas CT; Schmid R; Rolser M; Kaaru E; Langgartner D; Rieber K; Strobel B; Eisele C; Wiech F; Jakob I; Gantner F; Herichova I; Vinisko R; Böcher WO; Visvanathan S; Shen F; Panzenbeck M; Raymond E; Reber SO; Delić D; Baum P Crohns Colitis 360; 2020 Jan; 2(1):otaa003. PubMed ID: 32551441 [TBL] [Abstract][Full Text] [Related]
19. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983 [TBL] [Abstract][Full Text] [Related]